drugset / Trial / NCT00569972
A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia
RandomizedParallel-groupDouble-blindTreatment
Summary
To demonstrate efficacy and characterize the dose response relationship of PD 0200390 on subjective wake after sleep onset in subjects with primary insomnia.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATAGABALIN | Small molecule | 15 mg | — |
| Subject | ATAGABALIN | Small molecule | 30 mg | — |
| Subject | ATAGABALIN | Small molecule | 45 mg | — |
| Subject | ATAGABALIN | Small molecule | 60 mg | — |